Biotech's new frontiers, policy's old problems — Daily read, 2026-09-30

Today's moves show big biotech bets on extreme longevity and targeted therapeutics, while policy makers fumble on health access and environmental protection, often missing the obvious.

In today's read: 1. Extreme Biotech Goes for the Source Code · 2. Obesity Drugs Push Past GLP-1 · 3. Policy Battles Against Public Health Basics · 4. Wellness Expands Beyond the Gym

1. Extreme Biotech Goes for the Source Code

This isn't about incremental health gains. It's about rewriting biological blueprints: gene-editing embryos, growing new organs from stem cells, or discovering entirely new gene-editing systems. It's hitting the nervous system's core programming.

Watch the ethics debates heat up as tech outpaces policy. Investors are funding the wildest ideas, pushing the boundaries of what's possible, and opening new markets for radical longevity and disease elimination.

Evidence from today:

Biotech founder makes case for gene-editing human embryos — Wired Science — Cathy Tie, founder of Origin Genomics, argues that gene-editing human embryos to correct hereditary diseases isn't just an option, it's a "moral imperative." This controversial biotech position comes as the technology advances, forcing a re-evaluation of ethical boundaries.
Gene therapy restores hearing for rare deafness — Nature News — Clinical trials in the UK and China are showing promising results for a gene therapy that restores hearing in children with DFNB9, a rare form of genetic deafness. The therapy replaces a faulty gene, allowing inner ear cells to produce otoferlin and properly transmit sound signals to the brain.
Immortal Dragons invests $40M in stem cell startup Renewal Bio — Longevity.Technology — Longevity fund Immortal Dragons just poured $40 million into Renewal Bio, an Israeli startup focused on regenerative medicine. Renewal Bio's 'Stembroid' platform claims to create patient-matched cells using natural developmental processes. The company was founded in 2022.
Anthropic Claims New CRISPR-Like System for Gene Editing — Wired Science — AI company Anthropic is claiming to have discovered a novel gene-editing system, distinct from CRISPR, with the potential to rewrite genetic code. This discovery comes from analyzing microbial DNA and protein sequences. The biotech community is waiting for peer-reviewed data, but the PR is already out there.
Osaka Hospital Performs First Heart Repair with iPS Cell Sheets — Deutsches Ärzteblatt — Keisatsu Hospital in Osaka, Japan, completed the world's first heart surgery using lab-grown heart muscle cell sheets derived from induced pluripotent stem cells (iPS cells). These cells were implanted onto the heart of a patient with severe heart failure, aiming to regenerate damaged cardiac tissue and improve function.

2. Obesity Drugs Push Past GLP-1

The GLP-1 story isn't over, but it's evolving. New drugs target multiple hormone receptors (GLP-1, GIP, glucagon, amylin) simultaneously. This complex hormonal modulation leads to higher weight loss percentages and, crucially, fewer gastrointestinal side effects, improving patient retention.

This signals a new wave of metabolic treatments. The market will see a shift towards more potent, tolerable options, raising questions about access and the long-term impact on the food and supplement industries.

Evidence from today:

Retatrutide trial shows up to 25% weight loss with triple-hormone drug — Ars Technica - Science & Health — Eli Lilly's experimental drug Retatrutide, which targets GLP-1, GIP, and glucagon receptors, helped participants lose up to 25% of their body weight in a Phase 2 trial. This triple-agonist approach suggests a potent effect on metabolism and blood sugar regulation. It could be a new tier in obesity and metabolic care.
Zealand Pharma's amylin drug shows 8-11% weight loss, fewer side effects — Inside Precision Medicine — Zealand Pharma and Roche's new amylin-based obesity drug, petrelintide, hit Phase II targets. The drug delivered 8–11% weight loss in trials and reportedly comes with fewer of the tough gastrointestinal side effects common in other incretin drugs. This suggests a potentially smoother path to body composition changes for some.
Eli Lilly's retatrutide leads 19% weight loss in type 2 diabetes — Inside Precision Medicine — A new Eli Lilly peptide, retatrutide, showed an average 19% body weight loss in people with obesity and type 2 diabetes during trials. This triple-agonist, designed to hit GLP-1, GIP, and glucagon receptors, significantly outpaced previous diabetes weight loss meds in a population notoriously difficult to treat.

3. Policy Battles Against Public Health Basics

Governments are still fighting over foundational health protections like clean air, safe food, and managing sugar intake. Policy implementation lags behind science, creating real physiological burdens on populations and driving up long-term healthcare costs.

Expect consumer demand for personal health solutions to grow louder as public systems fail to protect basic health. Industry players with clear environmental or nutritional stances will gain trust, while regulators face increasing pressure from voters.

Evidence from today:

EU States Block Indefinite Pesticide Approvals, Targets Glyphosate — Deutsches Ärzteblatt — EU member states are pushing back against the European Commission's plan to allow indefinite approval for many pesticides, including glyphosate. They want to limit unlimited renewals only to low-risk substances, ensuring regular re-evaluations for others. This signals a shift towards stricter regulation of chemicals linked to gut and nervous system health.
Germany plans sugar-sweetened beverage tax by summer 2027 — Deutsches Ärzteblatt — Germany is moving forward with plans for a sugar-sweetened beverage tax, aiming to implement it by summer 2027. The proposed law, seen by Deutsches Ärzteblatt, mirrors the UK's 'sugar tax' model, which has been shown to reduce sugar content in drinks. This policy aims to improve public health by influencing consumption and, by extension, blood sugar regulation and metabolic health.
Australian doctors push for national clean air strategy — Croakey Health Media — Major Australian health groups, including GPs and lung specialists, are campaigning for a National Healthy Air Strategy. They argue clean air is a critical public health issue and a cost-effective government investment. They want the government to treat air quality like other health threats.
Food safety becomes 'kitchen-table' political issue — KFF Health News — Recent foodborne illness outbreaks and major recalls are pushing food safety up the political agenda for voters. This shift means regulators might face more pressure to enforce stricter standards on food production and labeling. It’s a sign that what you eat, and how it’s produced, is moving from niche concern to mainstream policy debate.

4. Wellness Expands Beyond the Gym

The market's definition of 'wellness' continues to broaden, pulling in new demographics and product forms. Creatine gummies, ingestible skincare, and melatonin for pain show supplements moving beyond fitness bros and into everyday ailments, driven by consumer demand for simple, accessible solutions.

Brands must adapt product delivery and marketing to capture this expanded audience. Expect more 'functional' foods, beverages, and accessible formats as the industry chases mainstream adoption, often without strong scientific evidence.

Evidence from today:

Creatine Gummies Signal Shift to Everyday Wellness Market — Nutritional Outlook — SIRIO Europe just dropped a new gummy portfolio for creatine, pushing the supplement beyond the usual gym crowd. This move is a clear signal that creatine wants to be seen as an everyday wellness staple, not just for elite athletes. Watch for more brands to follow this form factor to tap into new consumer segments.
Ingestible skincare isn't a fad, it's about the gut-skin axis — Nutritional Outlook — A Q&A with Maypro's Lauren Clardy points to a future where ingestible supplements become as crucial as topical creams for skin and hair health. The shift focuses on scientific backing for how gut health, inflammation, and cellular nutrition affect your appearance from the inside out. This isn't just about glowing skin; it's about a deeper understanding of the body's internal systems at play.
Resistance bands for seniors get 2026 update — Rebooted Body — A new guide identifies the top resistance bands for seniors in 2026, focusing on low-impact strength training, mobility, and rehabilitation. This move surfaces the continued demand for accessible home fitness tools, particularly for older adults aiming to maintain muscle mass and prevent injury.
Melatonin helps chronic pain, works like meds but safer — Vitafoods Insights — A new review suggests melatonin can relieve chronic musculoskeletal pain, showing effects similar to common pain medications. Researchers found it could be a safer alternative for long-term use. This covers nerve pain, back pain, and muscle issues without the typical side effects.

Also moved today

German Hospitals Urge Bureaucracy Cuts to Save Staff Time — Deutsches Ärzteblatt — German hospitals want less red tape, arguing bureaucracy drains medical staff from direct patient care, impacting nervous system regulation for caregivers and patients alike.
Heart Rehab Gap: Men Outnumber Women 3-to-1 in Germany — Deutsches Ärzteblatt — Men in Germany are three times more likely to get cardiac rehab than women, highlighting a massive post-event care gap for heart disease, which affects both sexes equally.
TikTok skincare trends linked to misleading claims and skin issues — Deutsches Ärzteblatt — TikTok skincare trends often lack science and cause real skin issues, showing the disconnect between viral fads and physiological reality.
Experts say knitting may slow cognitive decline, not halve dementia risk — Videnskab.dk (Health) — Knitting won't halve your dementia risk, say Danish researchers; complex manual tasks help cognition by building cognitive reserve, but don't promise miracle cures.
ECRM data hints at rising US demand for sleep, mental health supplements — Nutritional Outlook — US retailers are seeing surging demand for sleep and mental health supplements, showing where consumer anxiety is hitting the market now.
World No. 1 Padel Player Balances Pro Sports and Medicine — El Médico Interactivo — The world's No. 1 padel player is also a doctor, showing how elite performance and a high-demand professional career can coexist when physical and cognitive load are balanced.
German teens boost energy drink sales, risking nervous system load — Deutsches Ärzteblatt — German teens are drinking more energy drinks, adding to their nervous system load and pointing to a growing trend of stimulant use among youth.
Sleep Food & Beverage Market Sees Rising Demand for Stress Relief — The Food Institute — Functional food brands are chasing consumer demand for sleep and stress relief, but face skepticism about health claims in this growing market.
Three ingredient companies secure funding at SupplySide Global — SupplySide Supplement Journal — Oleolive, Ful Foods, and Nutriventia secured funding for novel ingredients targeting metabolic health and gut support, signaling investor confidence in science-backed nutrition.
Probiotical launches vaginal health capsules, allergy oral strips — Nutritional Outlook — Probiotical launched vaginal health capsules and allergy oral strips, moving probiotics beyond general gut health into targeted consumer wellness markets.

New this week in wellness goods

Creatine Gummies Signal Shift to Everyday Wellness Market — global — SIRIO Europe just dropped a new gummy portfolio for creatine, pushing the supplement beyond the usual gym crowd. This move is a clear signal that creatine wants to be seen as an everyday wellness staple, not just for elite athletes. Watch for more brands to follow this form factor to tap into new consumer segments.
Deep Longevity launches Accrua telehealth for biological age — US — Deep Longevity is bringing its Accrua digital health platform to the US in October 2026, offering AI-generated BloodAge reports nationwide. The service uses routine blood tests to estimate biological age, then anchors clinician-guided plans around those results.
Probiotical launches vaginal health capsules, allergy oral strips — north_america — Ingredient maker Probiotical is pushing beyond traditional gut health, launching two new consumer products: a vaginal microbiome capsule and an allergy-focused oral strip. Both leverage pro- and postbiotics, signaling a broader application for these ingredients in consumer wellness. It's a move to capture more specific, targeted markets outside of general digestive support.

Signal map

Global: 18 · Europe: 13 · North America: 12 · Oceania: 3 · UK & Ireland: 1 · Nordics: 1

What I'd watch next

Keep an eye on how these advanced biotech therapies navigate regulatory bodies and public opinion. The ethical lines are getting blurrier, and the public will eventually weigh in. Also, watch for the next flavor trend that displaces pumpkin as brands chase the shifting palate.

Where this fits at Kokorology

These market signals highlight how external loads drive internal needs. For an internal resource that helps you navigate these shifts without adding to your load, I reach for my Nervous System Journal.